TOFACITINIB IMPROVES DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES (PROS) IN PATIENTS (PTS) WITH ACTIVE PSORIATIC ARTHRITIS (PSA) IN REAL CLINICAL PRACTICE.

被引:1
|
作者
Korotaeva, T. [1 ]
Vorobyova, L. [1 ]
Loginova, E. [1 ]
Gubar, E. [1 ]
Korsakova, Y. [1 ]
Glukhova, S. [1 ]
Karpova, P. [1 ]
机构
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
关键词
D O I
10.1136/annrheumdis-2020-eular.2620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0845
引用
收藏
页码:1725 / 1725
页数:1
相关论文
共 50 条
  • [11] Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib
    Laura C. Coates
    Andrew G. Bushmakin
    Oliver FitzGerald
    Dafna D. Gladman
    Lara Fallon
    Joseph C. Cappelleri
    Ming-Ann Hsu
    Philip S. Helliwell
    Arthritis Research & Therapy, 23
  • [12] Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib
    Coates, Laura C.
    Bushmakin, Andrew G.
    FitzGerald, Oliver
    Gladman, Dafna D.
    Fallon, Lara
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    Helliwell, Philip S.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [13] Golimumab Improves Patient-Reported Outcomes In Patients With Active Rheumatoid Arthritis
    Dasgupta, B.
    Bertin, P.
    Settas, L.
    Fonseca, J. E.
    Wolff, V.
    Yao, R.
    Govoni, M.
    Vastesaeger, N.
    Weng, H. H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S209 - S209
  • [14] SECUKINUMAB IMPROVES CLINICAL AND PATIENT-REPORTED OUTCOMES AT 6 MONTHS AMONG PATIENTS WITH PSORIATIC ARTHRITIS IN THE US-BASED CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY
    Mease, P. J.
    Blachley, T.
    Glynn, M.
    Dube, B.
    Mclean, R.
    Kim, N.
    Hur, P.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1165 - 1165
  • [15] THE CONTRIBUTION OF JOINT SYMPTOMS, ENTHESITIS, SKIN AND NAIL PSORIASIS (PSO) TO MINIMAL DISEASE ACTIVITY (MDA) ACHIEVEMENT IN PSORIATIC ARTHRITIS (PSA) PATIENTS (PTS). EFFECT OF TOFACITINIB TREATMENT. DATA FROM REAL CLINICAL PRACTICE.
    Chamurlieva, M.
    Loginova, E.
    Gubar, E.
    Korsakova, Y.
    Glukhova, S.
    Korotaeva, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1669 - 1669
  • [16] Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Karki, Chitra
    Palmer, Jacqueline B.
    Etzel, Carol J.
    Kavanaugh, Arthur
    Ritchlin, Christopher T.
    Malley, Wendi
    Herrera, Vivian
    Tran, Melody
    Greenberg, Jeffrey D.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (11) : 1692 - 1699
  • [17] Changes in Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Ixekizumab in a Real-World US Cohort
    Tillett, William
    Birt, Julie
    Cavanaugh, Cristi
    Jung, Yoojin
    Vadhariya, Aisha
    Ross, Sarah
    Paulus, Jessica
    Sprabery, Aubrey
    Lubrano, Ennio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 750 - 752
  • [18] CHANGES IN DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH IXEKIZUMAB IN A REAL-WORLD US COHORT
    Birt, J.
    Tillett, W.
    Cavanaugh, C.
    Jung, Y.
    Vadhariya, A.
    Ross, S.
    Paulus, J.
    Sprabery, A. T.
    Lubrano, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 851 - 852
  • [19] ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Mease, P. J.
    Gottlieb, A. B.
    Ogdie, A.
    Assudani, D.
    Coarse, J.
    Ink, B.
    Coates, L. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1683 - 1683
  • [20] Patient-Reported Outcomes Differentiate Between Remission and Low Disease Activity in Psoriatic Arthritis
    Yedimenko, Juliette
    Walsh, Jessica
    Ogdie, Alexis
    Jin, Yuxuan
    Reddy, Soumya
    Scher, Jose
    Husni, M. Elaine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72